Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation: A Multicenter, Open-label, Randomized Clinical Trial

NCT07444372 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT07444372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07444372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation: A Multicenter, Open-label, Randomized Clinical Trial
Lead sponsor
Beijing Anzhen Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 12, 2026
Completion date
January 31, 2029
Enrollment
658 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, atrial fibrillation (af), continuous positive airway pressure, obstructive sleep apnea, sleep disorder (disorder), sleep disordered breathing (sdb)